ReviewCurrent neurology and neuroscience reports2026
Network-guided Thalamic Neuromodulation for Epilepsy.
Review in Current neurology and neuroscience reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
purpose of reviewThis review takes a network-based perspective on thalamic neuromodulation for epilepsy, examining how each target (e.g., anterior (ANT), centromedian (CM), and pulvinar (PUL) thalamic nuclei) engage distinct seizure networks, what evidence supports each, and how stimulation/electrophysiologic mapping can guide individualized targeting rather than a fixed, syndrome-based approach. RECENT
findingsRandomized and prospective trials have expanded the evidence for ANT and CM stimulation, while emerging data support the pulvinar as a target for posterior quadrant and temporal lobe epilepsies. Syndrome-specific sweet-spot analyses reveal distinct optimal sites within the CM for LGS and IGE. Thalamic sEEG with single-pulse stimulation and trials of DBS-style stimulation now enables characterization of seizure network engagement and identification of acute biomarkers that may inform target and parameter selection. Multi-target strategies combining thalamic nuclei, or thalamic and cortical leads, show preliminary promise for broadly distributed seizure networks. No single thalamic target is uniformly effective across epilepsy types; optimal targeting requires individualized, network-informed characterization. This supports a shift toward connectomic and individualized approaches, with future work needed to refine target selection, stimulation paradigms, and individualized optimization using clinical outcomes and electrophysiological biomarkers.
Indexed as
Identifiers
42891881What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.